Close

Click Bait for Your Health: How a Toronto Startup Uses Digital Engagement to Increase Medication Adherence

Posted on November 20, 2015 by Amos Adler

Using digital engagement to increase medication adherence is our novel solution to a complex problem. With non-adherence caused by multiple factors unique to each individual patient, a-one-size-fits-all-solution can’t work and won’t work. Instead, at MEMOTEXT we personalize each patient’s support program. By encouraging patient input, adapting to changes in mood and lifestyle, we can develop a medication adherence and support program that works best.

Read More

If I had $290 billion: Breaking Down the Cost of Medication Compliance

Posted on November 05, 2015 by Noah Nemoy

Medication Compliance is one of the biggest costs to worldwide healthcare systems. 50% of all patients do not take their medication as prescribed and this costs the U.S. healthcare system alone $290 billion per year. That’s a pretty massive figure that can be interpreted in several ways.

We can start by breaking down that $290 billion to show exactly how low compliance rates create such a huge cost:

Read More

EmpathyX – My MedXHangover Elixer

Posted on October 02, 2015 by Amos Adler

Keywords: #MedXHangover #EmpathyX #MedXorcism, #ActionX

So I’m currently suffering from what’s known as #MedXHangover. Its real, I assure you. Fortunately I don’t have #SyndromeX, a condition associated with attending uncomfortable doctor-patient simulations to simulate uncomfortable doctor-patient interactions.

Read More

MEMOTEXT Goes to the Canadian Psychiatric Association (CPA) Annual meeting in Vancouver, BC.

Posted on September 30, 2015 by Bill Simpson

As the Director of Scientific Development for MEMOTEXT I am honoured to have been invited to speak at this year’s Canadian Psychiatric Association (CPA) annual conference. The 2015 conference runs from Annual Conference October 1st – 3rd in Vancouver, British Columbia. I will be speaking at the “A clinician’s guide to mental health apps.” symposium on Thursday, October 1st at 10:15 PST. The focus of my contribution will be on mHealth and its capacity to affect positive behavioural change.

Read More

MEMOTEXT Founder and President Amos Adler to Present at Stanford Medicine X 2015

Abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” to be presented at conference main stage

Toronto, ON September 16, 2015 – MEMOTEXT is pleased to announce that our Founder and President Amos Adler will be a main stage speaker at Stanford Medicine X 2015. Running from September 23-27 in the heart of Silicon Valley, Medicine X is a catalyst for sharing new ideas on the intersection of healthcare and emerging technologies. Hosted by Stanford University, Medicine X brings together both business and academia for a 4 day conversation on the future of healthcare.

Read More

The Meaning of “Meaningful Use”

How MEMOTEXT helps you achieve it

Posted on October 13, 2015 by Noah Nemoy

If you’re an American health care provider or are involved in digital health, odds are you’ve been hearing a lot about Meaningful Use (MU) Stage 3 in recent years. But what is it exactly? Why does it matter? And while we’re at it, what is MU Stages 1 and 2?

Read More

MEMOTEXT Publishes Whitepaper on Patient Adherence & Digital Health Interventions

“The MEMOTEXT Toolkit” walks readers through the problem of patient non-adherence, explaining the methodology behind our digital health interventions

Posted on July 23, 2015 by Noah Nemoy

MEMOTEXT is pleased to unveil “The MEMOTEXT Toolkit” Whitepaper. Authored by MEMOTEXT’s President and Founder Amos Adler M.Sc., Director of Scientific Development Bill Simpson P.hD(c) and Miki Peer P.hD(c), the document explains both the problem of patient adherence and outlines the science behind MEMOTEXT’s methodology.

Read More

We’re Going to Stanford!

MEMOTEXT Founder and President Amos Adler to Present at Stanford Medicine X 2015

Posted on July 23, 2015 by Noah Nemoy

MEMOTEXT is pleased to announce that our President and Founder Amos Adler will be speaking at Stanford Medicine X 2015! Running from September 23-27 in the heart of Silicon Valley, Medicine X is a catalyst for sharing new ideas on the intersection of healthcare and emerging technologies. Hosted by Stanford University, Medicine X brings together both business and academia for a 4 day conversation on the future of healthcare.

Read More

MEMOTEXT Makes the Top 20

MEMOTEXT is named by HIT Consultant as one of the Top 20 Canadian Digital Health Technology Start-Ups to Watch

Posted on July 23, 2015 by Noah Nemoy

Earlier this month HIT Consultant, released their list of the Top 20 Canadian digital health companies to lookout for. The companies on the list were selected for their potential for growth and represented disparate areas of digital health, including digital health solutions, diagnostics, and patient centred care. MEMOTEXT managed to not only make the Top 20, but was also one of the Top 10 digital health start-ups in Eastern Canada, and the only company of the 20 with an exclusive focus on patient adherence.

Read More